Jan 21,2022

What’s next for AppliedVR after its FDA De Novo

Late last year, virtual reality therapeutic company AppliedVR scored FDA De Novo clearance for its EaseVRx system for treating chronic lower back pain. The system uses regulation and mindfulness skills, as well as techniques from cognitive behavioral therapy, to help patients control their physical symptoms alongside other mental and social health problems.

#virtual reality

#cbt

View Analyst & Ambassador Comments
Go to original news
Feb 04,2022

Characteristics of Mobile Health Platforms for Depression and Anxiety: Content Analysis Through a Systematic Review of the Literature and Systematic Search of Two App Stores

Mobile health (mHealth) platforms show promise in the management of mental health conditions such as anxiety and depression. This has resulted in an abundance of mHealth platforms available for research or commercial use. The objective of this review is to characterize the current state of mHealth platforms designed for anxiety or depression that are available for research, commercial use, or both.

CLINICAL STUDY

#mobile app

#cbt

View Analyst & Ambassador Comments
Go to original news
Feb 16,2022

Better Therapeutics Enrolls First Patient in Real World Evidence Study with Colorado Prevention Center Clinical Research

Better Therapeutics in partnership with Colorado Prevention Center (CPC) Clinical Research, today announced the first patient has been enrolled in a real-world evidence study to evaluate the long-term effectiveness and healthcare utilization changes associated with the use of BT-001 for the treatment of type 2 diabetes. The open-label, randomized, controlled study is actively recruiting patients with type 2 diabetes from the University of Colorado Health System.

PRODUCT

#pdt

#cbt

View Analyst & Ambassador Comments
Go to original news
Feb 24,2022

NHS LANARKSHIRE PROMOTES MIND MATTERS WEBSITE

NHS Lanarkshire is raising awareness of Lanarkshire Mind Matters which puts high-quality mental health self-help at people's fingertips. Lanarkshire Mind Matters offers free resources to help people with anxiety, depression and sleep issues. They include SilverCloud, Big Health's Daylight and Sleepio, and CBT courses from Beating The Blues.

PRODUCT

#cbt

View Analyst & Ambassador Comments
Go to original news
Mar 03,2022

Better Therapeutics Sponsors Educational Symposium on the Use of Software as a Next-Generation Treatment for Cardiometabolic Diseases

Better Therapeutics, Inc. (“Better Therapeutics”, NASDAQ: BTTX), a prescription digital therapeutics company developing cognitive behavioral therapy to address the root causes of cardiometabolic diseases, in collaboration with MedEd On The Go, today announced the availability of an on-demand, educational symposium entitled, “Next Generation Therapeutics for Cardiometabolic Diseases: Using Software Instead of Drugs.” The educational symposium can be accessed in its entirety via: www.mededonthego.com/refer/name/BetterTxPR852

#cbt

#pdt

View Analyst & Ambassador Comments
Go to original news
Mar 09,2022

Sober Grid collaborates with Walgreens and Orexo to bring customers Peer Coaching, the Sober Grid community, and Digital Therapeutics

Sober Grid, the world’s largest social media community for those in recovery, continues to expand their reach by joining the Walgreens Find Care® digital health platform. In recent months, Sober Grid has added services such as Orexo’s clinically proven Digital Therapeutics, vorvida® and deprexis®, to assist those suffering from mental health and substance abuse issues. Customers of either of these therapeutics are provided with complimentary Peer Coaching through the Sober Grid app, and Walgreens Find Care users will also have the ability to join Sober Grid’s mobile sober community, which offers live peer coaching, check-ins, and resources.

COLLABORATION PARTNERSHIP

#product & service

#coaching

#cbt

View Analyst & Ambassador Comments
Go to original news
Mar 15,2022

Better Therapeutics Announces Positive Primary Endpoint Data From Pivotal Clinical Trial of BT-001 for Patients With Uncontrolled Type 2 Diabetes

Better Therapeutics, Inc. (“Better Therapeutics”, NASDAQ: BTTX), a prescription digital therapeutics company developing nutritional cognitive behavioral therapy (nCBT) to address the root causes of cardiometabolic diseases, today announced primary endpoint data from its pivotal trial of BT-001, a first-in-class investigational PDT platform that is designed to use digitally delivered nCBT to treat type 2 diabetes. The primary efficacy endpoint (n=602) showed highly statistically significant improvement in A1c between the intervention and control groups. There was a clear dose-response between greater engagement in nCBT and greater reductions in A1c, supporting nCBT as a mechanism of action.

CLINICAL STUDY

#pdt

#cbt

View Analyst & Ambassador Comments
Go to original news
Mar 28,2022

A Smartphone-Based Intervention as an Adjunct to Standard-of-Care Treatment for Schizophrenia: Randomized Controlled Trial

Antipsychotic medications have limited benefits in schizophrenia, and cognitive behavioral therapy may be beneficial as an adjunct. There may be potential for implementing mobile cognitive behavioral therapy–based treatment for schizophrenia in addition to standard antipsychotic medications. This study aims to determine whether PEAR-004, a smartphone-based investigational digital therapeutic, improves the symptoms of an acute psychotic exacerbation of schizophrenia when it is added to standard treatments.

CLINICAL STUDY

#mobile app

#cbt

View Analyst & Ambassador Comments
Go to original news
Apr 06,2022

OxfordVR Technology a World First Success in Automating Psychological Therapy Using Virtual Reality (VR)

OxfordVR has successfully automated psychological therapy in VR for patients with mental illness. Users are guided by a virtual coach instead of a real-life therapist, allowing the treatment to reach many more patients. The technology, called gameChangeVR is a 6 week, automated, VR treatment that delivers cognitive behavioral therapy (CBT) inside safe, immersive, virtual scenarios. In the largest ever clinical trial of VR for mental health published today in The Lancet Psychiatry, gameChange was shown to help patients with schizophrenia and mood disorders with psychotic symptoms who suffer anxiety and distress in everyday situations.

PRODUCT

#cbt

#virtual reality

View Analyst & Ambassador Comments
Go to original news
Apr 06,2022

Better Therapeutics Announces Key Milestones and Updates for Ongoing Studies of its Digital Therapeutics Approach for Cardiometabolic Diseases

Better Therapeutics, Inc. (NASDAQ: BTTX), a prescription digital therapeutics (PDT) company developing nutritional cognitive behavioral therapy (nCBT) to address the root causes of cardiometabolic diseases, today announced several key research milestones designed to advance and further validate its therapeutic technologies, including the first ever study of nCBT as potential treatment for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH).

CLINICAL STUDY

#pdt

#cbt

View Analyst & Ambassador Comments
Go to original news
Subscribe to CBT